| 000 | 01599 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518034316.0 | ||
| 264 | 0 | _c20200430 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a2051-817X | ||
| 024 | 7 |
_a10.14814/phy2.14043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThapa, Dharendra | |
| 245 | 0 | 0 |
_aAdropin reduces blood glucose levels in mice by limiting hepatic glucose production. _h[electronic resource] |
| 260 |
_bPhysiological reports _c04 2019 |
||
| 300 |
_ae14043 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiet, High-Fat _xadverse effects |
| 650 | 0 | 4 | _aGluconeogenesis |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xpharmacology |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 700 | 1 | _aXie, Bingxian | |
| 700 | 1 | _aManning, Janet R | |
| 700 | 1 | _aZhang, Manling | |
| 700 | 1 | _aStoner, Michael W | |
| 700 | 1 | _aHuckestein, Brydie R | |
| 700 | 1 | _aEdmunds, Lia R | |
| 700 | 1 | _aZhang, Xueyang | |
| 700 | 1 | _aDedousis, Nikolaos L | |
| 700 | 1 | _aO'Doherty, Robert M | |
| 700 | 1 | _aJurczak, Michael J | |
| 700 | 1 | _aScott, Iain | |
| 773 | 0 |
_tPhysiological reports _gvol. 7 _gno. 8 _gp. e14043 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.14814/phy2.14043 _zAvailable from publisher's website |
| 999 |
_c29607578 _d29607578 |
||